 |
|
Could hormones explain gender differences in neurological disease?
June 16, 2009Neurological diseases including Parkinson's, Tourette's, attention deficit hyperactivity disorder (ADHD), Alzheimer's, and schizophrenia are all associated with alterations in dopamine-driven function involving the dopamine transporter (DAT). Research published today in the open access journal BMC Neuroscience suggests that a number of estrogens acting through their receptors affect the DAT, which may explain trends in timing of women's susceptibility to these diseases.
Rebecca Alyea and Cheryl Watson from the University of Texas Medical Branch investigated how physiological estrogen levels might influence neurochemical pathways including dopamine signalling. The authors tested the rapid nongenomic effects of several physiological estrogens (estradiol, estrone, and estriol) on dopamine efflux via the DAT in a non-transfected rat neuronal cell culture model that expresses the three membrane estrogen receptors ERα, ERß, and GPR30.
The authors found that estradiol-mediated dopamine efflux is DAT-specific and not dependent on extracellular Ca2+-mediated vesicular release of dopamine. Using kinase inhibitors they also showed that estradiol-mediated dopamine efflux is dependent on specific signaling kinases (protein kinase C and MEK, but not on PI3K or protein kinase A). While inhibiting dopamine efflux, estrone and estriol caused DAT to leave the plasma membrane.
Previous work by Alyea and Watson indicated that the suppression of efflux occurs mainly via ERα, and in this new study they show a physical association of ERα and ERß with DAT before and during estrogen action, and trafficking of all three estrogen receptors in and out of the plasma membrane during dopamine efflux.
"The significance of estrogen-coupled regulation of the DAT by both direct and indirect (kinase-mediated) interactions between estrogen receptors and the DAT should provide insights into how neurological diseases which involve the DAT are related to developmental, gender, and life stage issues," says Watson. "Such regulation may suggest new ideas about treatment and prevention of diseases associated with extreme hormonal fluctuations such as in postpartum depression."
Women experience significant estrogen level changes at various life stages such as adolescence, menopause and as a result of monthly cycles. Women are also most likely to experience the onset or exacerbations of some neurological diseases at these times.
BioMed Central
Previous work by Alyea and Watson indicated that the suppression of efflux occurs mainly via ERα, and in this new study they show a physical association of ERα and ERß with DAT before and during estrogen action, and trafficking of all three estrogen receptors in and out of the plasma membrane during dopamine efflux.
"The significance of estrogen-coupled regulation of the DAT by both direct and indirect (kinase-mediated) interactions between estrogen receptors and the DAT should provide insights into how neurological diseases which involve the DAT are related to developmental, gender, and life stage issues," says Watson. "Such regulation may suggest new ideas about treatment and prevention of diseases associated with extreme hormonal fluctuations such as in postpartum depression."
Women experience significant estrogen level changes at various life stages such as adolescence, menopause and as a result of monthly cycles. Women are also most likely to experience the onset or exacerbations of some neurological diseases at these times.
BioMed Central
Dopamine Current Events and Dopamine News RSSISU researchers' findings bring hope for possible Parkinson's disease cure
Researchers at Iowa State University have found an essential key to possibly cure Parkinson's disease and are looking for others.
Widely used cholesterol-lowering drug may prevent progression
Simvastatin, a commonly used, cholesterol-lowering drug, may prevent Parkinson's disease from progressing further. Neurological researchers at Rush University Medical Center conducted a study examining the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Stress-induced changes in brain circuitry linked to cocaine relapse
Stress-evoked changes in circuits that regulate serotonin in certain parts of the brain can precipitate a low mood and a relapse in cocaine-seeking, based on mouse studies published online this week in the Proceedings of the National Academy of Sciences.
Researchers find brain cell transplants help repair neural damage
A Swiss research team has found that using an animal's own brain cells (autologous transplant) to replace degenerated neurons in select brain areas of donor primates with simulated but asymptomatic Parkinson's disease and previously in a motor cortex lesion model, provides a degree of brain protection and may be useful in repairing brain lesions and restoring function.
Changes in brain chemicals mark shifts in infant learning
When do you first leave the nest? Early in development infants of many species experience important transitions-such as learning when to leave the protective presence of their mother to start exploring the wider world.
Why antidepressants don't work for so many
More than half the people who take antidepressants for depression never get relief.
Cocaine exposure during pregnancy leads to impulsivity in male, not female, monkeys
Adult male monkeys exposed to cocaine while in the womb have poor impulse control and may be more vulnerable to drug abuse than female monkeys, even a decade or more after the exposure, according to a new study by researchers at Wake Forest University School of Medicine. The findings could lead to a better understanding of human drug abuse.
Scientists demonstrate link between genetic defect and brain changes in schizophrenia
Researchers at the University of North Carolina at Chapel Hill School of Medicine have found that the 22q11 gene deletion - a mutation that confers the highest known genetic risk for schizophrenia - is associated with changes in the development of the brain that ultimately affect how its circuit elements are assembled.
Fine-tuning treatments for depression
New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression.
Study supports possible role of urate in slowing Parkinson's disease progression
By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases (MGH-MIND) and Harvard School of Public Health (HSPH), has found evidence supporting the findings of their 2008 study - that elevated levels of the antioxidant urate may slow the progression of Parkinson's disease.
More Dopamine Current Events and Dopamine News Articles
 |
The Craving Brain: A bold new approach to breaking free from *drug addiction *overeating *alcoholism *gambling by Ronald A. Ruden (Author) Where do the roots of addictive behavior lie -- in our genes or in our environment, in our chemistry or in our character?In the Craving Brain, Dr. Ronald Ruden asserts that the roots of addiction most defintetly do not lie in our character. Rather, they lie in a complex chain reaction that originates in an ancient survival mechanism in the brain. When this system is inappropriately activated, it drives the body to crave, sometimes with addictive behavior as the end result. In clear, straightforward language, Dr. Ruden outlines his remarkable successful treatment program which he believes can cure this problem. The Craving Brain offers crucial insights into the world of addiction. This revolutionary book will bring hope to millions of people who suffer from a wide range of... |
 |
Dopamine Handbook by Leslie Iversen (Author), Susan Iversen (Author), Stephen Dunnett (Author), Anders Bjorklund (Author) The discovery of dopamine in 1957-1958 was one of the seminal events in the development of modern neuroscience, and has been extremely important for the development of modern therapies of neurological and psychiatric disorders. Dopamine has a fundamental role in almost all aspects of behavior: from motor control to mood regulation, cognition and addiction and reward, and dopamine research has been unique within the neurosciences in the way it has bridged basic science and clinical practice. Over the decades research into the role of dopamine in health and disease has been in the forefront of modern neuroscience. The Dopamine Handbook is the first single-volume publication to capture current progress and excitement in this dynamic research field. |
 |
Imaging Dopamine by Paul Cumming (Author) Since its discovery 50 years ago, brain dopamine has been implicated in the control of movement and cognition, and is concerned with diverse brain diseases such as Parkinson's disease, schizophrenia and drug addiction. This book is an illustrated biography of the dopamine molecule, from its synthesis in the brain to its signalling mechanisms and ultimately to its metabolic breakdown. Using colour illustrations of positron emission tomography (PET) scans, each chapter presents a specific stage in the biochemical pathway for dopamine. Writing for researchers and graduate students, Paul Cumming presents a compilation of all that has been learned about dopamine through molecular imaging, a technology which allows the measurement of formerly invisible processes in the living brain. He reviews... |
 |
Dumb Bells & Dopamine: A Parkinson's Success Story by Arthur Curren (Author) This book is about living with Parkinson's, an incurable, debilitating disease caused by the loss of dopamine-producing cells in the brain of the afflicted person. Levodopa is the only drug that replaces some of the dopamine and exercise is the only activity that induces the brain to produce dopamine. The author uses a rigorous exercise program to reduce the dosage of levodopa and extend the useful life of this essential drug. This is the author's dumb bells and dopamine approach to controlling Parkinson's.The author has also addressed some of the social issues related to the disease. This includes dealing with less than perfect physicians and with the negative situations that exist in the insurance industry and Social Security Administration.To provide real assistance to people with the... |
 |
Source Naturals N-Acetyl L-Tyrosine 300mg, 120 tablets by Source Naturals Dietary supplement. N-Acetyl L-Tyrosine is a more rapidly absorbed and bioavailable form of the amino acid L-tyrosine, and is less prone to urinary excretion. L-Tyrosine is converted in the body to key biologic compounds, including epinephrine, dopamine, L-dopa, CoQ10, thyroid hormones, and melanin. The B vitamins pyridoxine (B-6) and folic acid are provided to assist in the conversion process (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease). Suitable for vegetarians. Contains no yeast, dairy, egg, gluten, soy or wheat. Contains no sugar, starch, preservatives, or artificial color, flavor or fragrance. |
 |
Dopamine Starring: Kathleen Antonia, Ian Berzon, Timothy Breitbach, Bruno Campos, Rueben Grundy Also With: John Livingston (Primary Contributor) Indie flick Dopamine wants to know: Is love a transcendent, spiritual experience, or simply the result of hormones like dopamine (a chemical in the brain that inspires pleasure)? Rand (John Livingston, Where's Marlowe?), a San Francisco computer programmer developing a virtual pet, is convinced it's all neurochemistry--until he meets Sarah (Sabrina Lloyd of the TV show Sliders), a teacher at a pre-school where the pet is being tested. During their nervous, awkward dates, he struggles to maintain his cynical, hormone-driven perspective as his feelings seem increasingly real. The dialogue and ideas in Dopamine are clever, if not exactly convincing; unfortunately, the pace and performances are stiff and morose--the romance feels more predetermined by the filmmakers' schematic plan... |
 |
Dopamine Research Advances by Akiyama Watanabe (Editor), Arcangelo Benigno (Editor) Dopamine is a phenethylamine naturally produced by the human body. In the brain, dopamine functions as a neurotransmitter, activating the five types of dopamine receptor - D1, D2, D3, D4 and D5, and their variants. Dopamine is produced in several areas of the brain, including the substantia nigra. Dopamine is also a neurohormone released by the hypothalamus. Its main function as a hormone is to inhibit the release of prolactin from the anterior lobe of the pituitary. Dopamine can be supplied as a medication that acts on the sympathetic nervous system, producing effects such as increased heart rate and blood pressure.However, since dopamine cannot cross the blood-brain barrier, dopamine given as a drug does not directly affect the central nervous system. To increase the amount of dopamine... |
 |
Dopamine, Volume 21 (Handbook of Chemical Neuroanatomy) by S.B. Dunnett (Editor), M. Bentivoglio (Editor), A. Björklund (Editor), T. Hökfelt (Editor) Dopamine is a major neurotransmitter of the brain involved in the control of movement, emotion, and cognition; disturbance in dopamine function is associated with disorders like Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
|
 |
Molecular Origins of Human Attention: The Dopamine-Folate Connection by Richard C. Deth (Author) This volume provides a highly integrated view of attention-related events, taking the reader from individual molecular interactions through the regulation of neuronal circuits to our higher order capacity for selective amplification of particular information. Neuroscientists, psychologists, psychiatrists and other professionals dealing with psychiatric illnesses such as ADHD, autism, and schizophrenia will find this volume a useful addition to their library. |
 |
Dopamine Transporters: Chemistry, Biology, and Pharmacology (Wiley Series in Drug Discovery and Development) by Mark L. Trudell (Editor), Sari Izenwasser (Editor), Binghe Wang (Editor) Understanding the dopamine transporter can lead to new therapies for neurological disorders This book consolidates current information on the dopamine transporter (DAT) in relationto medicinal chemistry and synthesis, biology and pathology, and pharmacology. Because of DAT's role in diseases such as Parkinson's, schizophrenia, attention deficit hyperactivity disorder (ADHD), Tourette syndrome, and drug abuse (in particular, cocaine addiction), DAT research is an exploding field. Tremendous advances have been made toward understanding how it impacts a variety of neurological disease states and disorders. |
| © 2009 BrightSurf.com |